| |
|
|
|
Corvus Pharma Com  
|
|
2.26 -0.03 (-0.01%) |
09-16 16:00 |
|
Open: |
2.28 |
Pre close: |
2.29 |
Target:
|
2.88
|
|
High: |
2.52 |
Low: |
2.22 |
Resistance:
|
2.47
2.84
|
|
Volume: |
457,747 |
Market Cap: |
87M |
Support:
|
1.86
1.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.35
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
2.32  |
Signal(12,26,9): |
0.07 |
|
MA(100): |
2.47 |
Stochastic Oscillator |
%K(14,3):
|
26.25 |
|
MA(250): |
3.22 |
%D(3): |
39.79 |
|
Average Volume(K) |
3-Month: |
975074
|
52-Week |
High:
|
5.74 |
|
10-Days: |
1578052 |
Low: |
1.86 |
|
RSI |
RSI(14):
|
47.38 |
Change(%): |
-49.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.156 |
Return on Equity (ttm) |
-6.0 |
Shares Out. (M) |
38.31 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-28.7 |
Shares Float (M) |
18.54 |
|
EPS Est. Next Year |
-3.410 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.85 |
|
EPS Est. Next Quarter |
-0.840 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
64.39 |
|
Forward EPS |
-1.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1200 |
|
Book Value (p.s.) |
2.460 |
EBITDA (p.s.) |
-1.080 |
P/E |
-14.49 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-34.21 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.29 |
P/CF |
-2.53 |
|
|
|
|
|
|
